CASCINATION @CAScination

Yr wythnos diwethaf – daeth CAS-One IR i Gymru! For those not fluent in Welsh, we are happy to welcome The Grange University Hospital (Aneurin Bevan University Health Board) to Quality Ablation! This project moved very quickly, and we are thankful to the team led by IRs Chris…

keyboard_arrow_left Previous keyboard_arrow_right Next

Nearly 12,000 patients have been treated globally with CAS-One IR, and last week we were very proud to recognize Dr. Marie Beermann, Dr. Jacob Freedman and the entire team at Danderyds Sjukhus for having treated 1,500 of those patients! Their dedication, and ongoing belief in…

keyboard_arrow_left Previous keyboard_arrow_right Next

Rise of the machines, velvet divorces, GPT-4 in IR, BOREALIS... The titles of the scientific talks at this year's Cardiovascular and Interventional Radiological Society of Europe (CIRSE) are riveting! It is the biggest IR event of the year globally, and for us also at…

New ablation intel unlocked: Now there are nearly 40 publications featuring CAS-One IR – the latest coming from two hospitals in Belgium – Antwerp University Hospital (UZA) and Erasme Hospital – Université libre de Bruxelles. They conducted a retrospective cohort study…

CAS-One IR just got a major upgrade with version 4.3 Dr. Shaheen Noorani walks you through the latest advancements in CAS-One IR version 4.3. Learn the new features and the impact: ✅ Oblique MPR view ✅ Lesion/Segmentation upgrades and measurement tools (MAM!) ✅ Anatomy Atlas,…

The definition of minimal ablative margin will likely evolve into a range of margins, shaped by factors like tumor histologic subtype and measurement technique. It's time to focus on achieving 100% lesionalized margins in 100% of patients. Paolucci et al.'s review on…

Rather than just confirming nearly complete margins, 100% margins must be achieved in 100% of treatments. CAS-One IR does just that. It provides immediate, objective, and quantitative feedback on ablation volume, empowering physicians to make informed re-ablation decisions in…

Last week, our CEO Stefan Weber, had the privilege of presenting Quality Ablation with CAS-One IR at the Clinical center University of Sarajevo. We were invited by Dr. Fuad Zukic, Head of Radiology, who pioneered the introduction of percutaneous tumor ablation in Bosnia and…

keyboard_arrow_left Previous keyboard_arrow_right Next

Ablation confirmation is gaining more and more attention, both on stage at major conferences and in scientific research. Meanwhile, AblaSure continues to be trusted in clinical practice, with hundreds of uses each month. To dive into these important topics, we're proud to…

Our ECIO preview is back. Rotterdam again brings a lot of important topics for ablation in general, as well as new things from Quality Ablation with CAS-One IR (including a record number of abstracts, sneak preview of the new software). Check out our blog post outlining what we…

On this day we present: CAS-One IR now with Ads. Soon hospitals will be able to collect valuable advertisement revenue from presenting online ads on CAS-One IR’s second screen, whenever it is not needed.

Brachytherapy isn’t one of the main procedures done with the help of CAS-One IR, but at the WEGE KLINIK symposium last week it was a highlight and generated lots of interest. Thanks to Attila Kovács for pushing this emerging use to the forefront and Michael Pinkawa for leading…

keyboard_arrow_left Previous keyboard_arrow_right Next

4,703 configurations. That’s not just a number, it’s precision at its finest. CAS-One IR integrates 4,703 carefully optimized ablation configurations from 120+ trusted ablation devices. This ensures interventional radiologists have seamless and broad access to the best possible…

Welcome to Quality Ablation @KSWinterthur! Arash Najafi and the team have treated multiple patients with complex liver tumors with CAS-One IR. The planning, and navigation capabilities are helpful in the complex cases (multi-needle, close to critical structures), and the…

keyboard_arrow_left Previous keyboard_arrow_right Next

This months Top Case is here: A 75-Year-old patient diagnosed in 2023 with a rectosigmoid cancer presented with two new hypervascular lesions in segment IVa in a cirrhotic liver during the follow-up. The MDT decided doing electrochemotherapy (ECT) on both lesions, with a…

Very recently, a group from 2 Hospitals in Germany published a study on ECT combined with CAS-One IR. Read the full publication here: pmc.ncbi.nlm.nih.gov/articles/PMC11…

Our first Top Case of the year is here: A 65 year old patient presented for follow-up regarding ongoing imaging for active surveillance of an unclear renal mass suspected to be papillary renal cell carcinoma in the left kidney. The lesion was visible on CT and a four needle…

The Society of Interventional Oncology is heading to Vegas—and so are we! Get ready to experience the game-changing power of CAS-One IR®. With its advanced planning, precise navigation, and the cutting-edge, AI-driven AblaSure®, we dont want you to gamble with ablation…

Welcome to Quality Ablation Barmherzige Schwestern Krankenhaus Wien! Dr. Helmut Kopf has already performed several liver and kidney treatments using the CAS-One IR system. Based on the positive experience and results, the hospital has decided to acquire the system by the end of…

keyboard_arrow_left Previous keyboard_arrow_right Next